Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
- 8 May 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (6), 2742-2751
- https://doi.org/10.1172/jci67398
Abstract
The heparan sulfate proteoglycan (HSPG) syndecan-1 (SDC1) acts as a major receptor for triglyceride-rich lipoprotein (TRL) clearance in the liver. We sought to identify the relevant apolipoproteins on TRLs that mediate binding to SDC1 and determine their clinical relevance. Evidence supporting ApoE as a major determinant arose from its enrichment in TRLs from mice defective in hepatic heparan sulfate (Ndst1f/fAlbCre+ mice), decreased binding of ApoE-deficient TRLs to HSPGs on human hepatoma cells, and decreased clearance of ApoE-deficient [3H]TRLs in vivo. Evidence for a second ligand was suggested by the faster clearance of ApoE-deficient TRLs after injection into WT Ndst1f/fAlbCre– versus mutant Ndst1f/fAlbCre+ mice and elevated fasting and postprandial plasma triglycerides in compound Apoe–/–Ndst1f/fAlbCre+ mice compared with either single mutant. ApoAV emerged as a candidate based on 6-fold enrichment of ApoAV in TRLs accumulating in Ndst1f/fAlbCre+ mice, decreased binding of TRLs to proteoglycans after depletion of ApoAV or addition of anti-ApoAV mAb, and decreased heparan sulfate–dependent binding of ApoAV-deficient particles to hepatocytes. Importantly, disruption of hepatic heparan sulfate–mediated clearance increased atherosclerosis. We conclude that clearance of TRLs by hepatic HSPGs is atheroprotective and mediated by multivalent binding to ApoE and ApoAV.Keywords
This publication has 68 references indexed in Scilit:
- Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemiaHepatology, 2012
- Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearanceHepatology, 2011
- Glucuronic Acid Epimerase is Associated with Plasma Triglyceride and High‐Density Lipoprotein Cholesterol Levels in TurksAnnals of Human Genetics, 2011
- A Comprehensive Compositional Analysis of Heparin/Heparan Sulfate-Derived Disaccharides from Human SerumAnalytical Chemistry, 2011
- Intravenous Injection of Apolipoprotein A-V Reconstituted High-Density Lipoprotein Decreases Hypertriglyceridemia in apoav −/− Mice and Requires Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein–Binding Protein 1Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteinsHepatology, 2010
- GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into CapillariesCell Metabolism, 2010
- Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein ClearancePublished by Elsevier BV ,2010
- Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of ChylomicronsCell Metabolism, 2007
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.JCI Insight, 1993